I have no idea. I'm no oncologist and the trial inclusion and exclusion criteria, and intervention description don't seem to speak to a specific chemo run-in.
I can imagine there would be a material difference between priming and treating in combination. Worth a question at the Q&A, or an email
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.13M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $228.5K | 20.76M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 4864829 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 11096194 | 47 |
View Market Depth
| Last trade - 11.41am 26/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |